EARLY DETECTION OF PROSTATE CANCER: KNOWLEDGE AND PRACTICE OF MALE HOSPITAL WORKERS IN A TERTIARY HOSPITAL, SOUTH EASTERN NIGERIA.

  • Uche C. L Department o f hematology Abia State University Teaching Hospital, Aba
  • Awa M. Department of Community medicine Abia State University Teaching Hospital, Aba
  • Ekeleme N. C Department of Community medicine Abia State University Teaching Hospital, Aba
  • Iwuoha E. C Department of Community medicine Abia State University Teaching Hospital, Aba
Keywords: PSA testing, Knowledge, Practice, ABSUTH

Abstract

Background: Incidence of Prostate cancer may be underestimated among Nigerians, but studies from different parts of Nigeria showed that Prostate cancer is the top male cancer and fourth commonest cancer in Nigeria among men ≥ 40 years. Prostate specific antigen (PSA) is an invaluable screening test for early diagnosis in asymptomatic men. However, reports abound of poor awareness about Prostate Specific Antigen (PSA) in this clime.

Objective: This study, aimed to ascertain the knowledge and practice of PSA for early detection of Prostate cancer among male hospital workers in Abia State University Teaching hospital.

Methodology: This was a hospital-based cross-sectional descriptive study carried out amongst randomly selected male workers from different departments. One hundred and one eligible respondents returned completed questionnaires (response rate = 84%).

Results: The mean age of respondents was 40.6± 9.4 years. Majority of the respondents 63(62.4%) had poor knowledge while only 38(37.4%) had good knowledge of PSA. There was a statistically significant association (p < 0.001) between knowledge scores regarding PSA and occupation of respondents. There was also a statistically significant relationship between respondents’ age and knowledge of PSA (p = 0.002). Health workers were 8 times more likely to have good knowledge of PSA compared to support staff; OR 8.09 95% CI (3.03-20.08). Only 12(11.9%) respondents had done a PSA in the past .Eighty three percent of the respondents agreed that they would practice PSA test if it was free, 9% disagreed and 8% were undecided.

Conclusion: The study identified poor knowledge and practice of PSA among these hospital staff and cost as the most important independent predictors of intention to practice PSA test.

Downloads

Download data is not yet available.

References

1. Delongchamps NB, Singh A, Haas GP. Epidemiology of prostate cancer in Africa: another step in the understanding of the disease? Curr Probl Cancer. 2007; 31; 3:226–36.
2. Garcia M, Jemal A, Ward EM, Center MM, Hao Y, Siegel RL, et al. Global cancer facts and figures 2007. American Cancer Society; Atlanta, GA: 2007.
3. Odedina FT, Ogunbiyi JO, Ukoli FA. Roots of prostate cancer in AfricanAmerican men. J Natl Med Assoc. 2006; 98; 4:539–43
4. Osegbe DN. Prostate cancer in Nigerians: acts and non-facts. J Urol. 1997; 157(4):1340–1343.
5. Ekwere PD, Egbe SN. The changing pattern of prostate cancer in Nigerians: current status in the southeastern states. J Natl Med Assoc. 2002;94;7:619–27.
6. Badmus TA, Adesunkanmi AR, Yusuf BM, Oseni GO, Eziyi AK, Bakare TI, Adetiloye JA, Badmus SA. Burden of prostate cancer in southwestern Nigeria. Urology. 2010;76;2:412–6..
7. Badmus TA, Adesunkanmi AR, Yusuf BM, et al. Burden of prostate cancer in southwestern Nigeria. Urology. 2010 Aug;76;2:412–6.
8. Mohammed AZ, Alhassan SU, Edino ST, Ochicha O. Histopathological review of prostatic diseases in Kano, Nigeria. Niger Postgrad Med J. 2003;10(1):1–5.
9. Afolayan EA. Five years of Cancer Registration at Zaria. Niger Postgrad Med J. 2004;11;3:225–9.
10.Akang EE, Aligbe JU, Olisa EG. Prostatic tumours in Benin City, Nigeria. West Afr J Med. 1996;15;1:56–60.
11.Dawam D, Rafindadi AH, Kalayi GD. Benign prostatic hyperplasia and prostate carcinoma in native Africans. BJU Int. 2000;85(9):1074–7.
12. Gondos A, Brenner H, Wabinga H, Parkin DM. Cancer survival in Kampala, Uganda. Br J Cancer. 9;92:1808–12.
13.Yawe KT, Tahir MB, Nggada HA. Prostate cancer in Maiduguri. West Afr J Med. 2006;25;4:298–300.
14. Brawer MK. Screening for prostate cancer. Semin Surg Oncol. 2000; 18:29–36
15. Burack RC, Wood DP., Jr screening for prostate cancer. The challenge of promoting the informed decision making in the absence of definitive evidence of
effectiveness. Med Clin North Am. 1999:83–1423.
16. Ukoli F, Osime U, Akereyeni F, Okunzuwa O, Kittles R, Adams Campbell L. Prevalence of elevated serum prostate-specific antigen in rural Nigeria. Int J Urol. 2003;10;6:315–22.
17. Igwe CU, Ikaraoha CI, Ogunlewe JO, Nwobu GO, Duru LAD, Mokogwu ATH. The Study Of Serum Prostate Specific Antigen And Phosphatase Isoenzymes Activity As Diagnostic Parameters In Patients With Prostate Cancer In Nigeria. J Health Allied Scs. 2004;3:3.
18.Abbiyesuku FM, Shittu OB, Oduwole OO, Osotimehin BO. Prostate specific antigen in the Nigerian African. Afr J Med Med Sci. 2000;29(2):97–100.
19. Kleihues P, Stewart BW. WHO/GLOBAL cancer rates could increase by 50% to 15 million by 2020; 2003
20. Nakandi H., Kirabo M., Semugabo C., Kittengo A., Kitayimbwa P. ,Kalung S., Maena A. Knowledge, attitudes and practices of Ugandan men regarding Prostrate cancer. African Journal of Urology 2013. 19; 4, 2013, Pages 165- 170
21. Ebuehi O.M. Otumu I.U. Prostrate screening practices among male staff of University of Lagos, Nigeria African Journal of Urology 17: 4, 2011. 122- 134
22. Prostate Cancer Foundation of Australia. Prostate cancer statistics. Available at: http://www.prostate.org.au/articleLive/pages/Prostate-Cancer-Statistics.html,
2010.
23. Bourne PA. Rural male health workers in Western Jamaica: Knowledge, attitudes and practices toward prostate cancer screening. North Am.J.Med.Sci. 2010;2:11-7.
24. Frosch Dominick L, Bhatnagar Vibha, Tally Steven, Hamori Charles J, Kaplan Robert M. Internet patient decision support: a randomized controlled trial comparing alternative approaches for men considering prostate cancer screening. Arch Intern Med. 2008 ;168;4:363–9.
25. Krist Alex H, Woolf Steven H, Johnson Robert E, Kerns J William. Patient education on prostate cancer screening and involvement in decision making. Ann Fam Med. 2007;5;2:112–9.
26. Oranusi C.K, Mbieri U.T, Oranusi I.O, Nwofor A.M.E. Prostate cancer Awareness and Screening Among Male Public Servants in Anambra State Nigeria: African Journal of Urology 2012 18 ;2;72-74.
27. Djulbegovic M, Beyth RJ, Neuberger MM, Stoffs TL, Vieweg J, Djulbegovic B, Dahm P.Screening for Prostate cancer; systematic review and metaanalysis of randomized control trials. BMJ 2010. 341: 4543.
28. Robbins AS, Whittemore AS, Thom DH. Differences in socioeconomic status and survival among White and Black men with prostate cancer. Am. J. Epidemiol.
2000;15;14:409-16.
29. Zimmerman SM. Factors influencing Hispanic participation in prostate cancer screening. Oncol.Nurs.Forum. 1997;24(3):499-504.
30. Oladimeji, Bidemi, YJA Olufisayo Y J A. A Sola A. Prostate cancer awareness, knowledge and screening practices among older men in Oyo State, Nigeria. Int Q Community Health Educ, 2010, 30 ;3 ; 271-286
31. Farra EF, Carvalhal GF, Vieira RAC, Silva TB, Mauad EC Carvalho AL, Program for prostate cancer screening using a mobile unit: results from Brazil. Urology, 2010, 76 ; 5; 1052-1057
How to Cite
1.
Uche C. L, Awa M., Ekeleme N. C, Iwuoha E. C. EARLY DETECTION OF PROSTATE CANCER: KNOWLEDGE AND PRACTICE OF MALE HOSPITAL WORKERS IN A TERTIARY HOSPITAL, SOUTH EASTERN NIGERIA. Med. res. chronicles [Internet]. 2017Aug.31 [cited 2024Nov.5];4(04):439-46. Available from: https://medrech.com/index.php/medrech/article/view/259
Issue
Vol. 4 No. 04 (2017): Jul-Aug
Section
Original Research Article